In HNSCC, overexpression of the epidermal growth factor receptor (EGFR), also known as HER1, has been detected in the majority of HPV-negative tumors and has been associated with reduced OS and increased risk of recurrence or metastasis [4,5]. This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.